vs
FATE THERAPEUTICS INC（FATE）与SemiLEDs Corp（LEDS）财务数据对比。点击上方公司名可切换其他公司
SemiLEDs Corp的季度营收约是FATE THERAPEUTICS INC的1.9倍（$2.6M vs $1.4M），SemiLEDs Corp同比增速更快（103.7% vs -26.4%），SemiLEDs Corp自由现金流更多（$331.0K vs $-112.0M），过去两年SemiLEDs Corp的营收复合增速更高（70.3% vs -15.7%）
因西斯治疗是1990年成立、总部位于亚利桑那州钱德勒的美国特色制药企业，核心产品Subsys是芬太尼的舌下含服液体制剂。芬太尼是一种见效极快的强效阿片类药物，用于缓解癌症患者爆发性疼痛，在美国，用于该适应症的芬太尼处方通常要求已有记录证明保守疗法无效。
该企业是涵盖电子设计与制造供应链相关企业的行业协会，为半导体、光伏板、发光二极管、平板显示器、微机电系统、印刷柔性电子及相关微纳米技术领域的制造提供设备、材料与服务支持。
FATE vs LEDS — 直观对比
营收规模更大
LEDS
是对方的1.9倍
$1.4M
营收增速更快
LEDS
高出130.1%
-26.4%
自由现金流更多
LEDS
多$112.4M
$-112.0M
两年增速更快
LEDS
近两年复合增速
-15.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4M | $2.6M |
| 净利润 | — | $-742.0K |
| 毛利率 | — | 0.7% |
| 营业利润率 | — | -39.4% |
| 净利率 | — | -28.9% |
| 营收同比 | -26.4% | 103.7% |
| 净利润同比 | 37.9% | -35.6% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FATELEDS
| Q4 25 | $1.4M | $2.6M | ||
| Q3 25 | $1.7M | $13.2M | ||
| Q2 25 | $1.9M | $17.7M | ||
| Q1 25 | $1.6M | $10.9M | ||
| Q4 24 | $1.9M | $1.3M | ||
| Q3 24 | $3.1M | $1.3M | ||
| Q2 24 | $6.8M | $1.3M | ||
| Q1 24 | $1.9M | $886.0K |
净利润FATELEDS
| Q4 25 | — | $-742.0K | ||
| Q3 25 | $-32.3M | $-1.2M | ||
| Q2 25 | $-34.1M | $223.0K | ||
| Q1 25 | $-37.6M | $388.0K | ||
| Q4 24 | — | $-547.0K | ||
| Q3 24 | $-47.7M | — | ||
| Q2 24 | $-38.4M | $-319.0K | ||
| Q1 24 | $-48.0M | $-559.0K |
毛利率FATELEDS
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | 12.6% |
营业利润率FATELEDS
| Q4 25 | — | -39.4% | ||
| Q3 25 | -1995.1% | -9.0% | ||
| Q2 25 | -1938.5% | -0.4% | ||
| Q1 25 | -2534.1% | 1.0% | ||
| Q4 24 | — | -52.1% | ||
| Q3 24 | -1703.9% | — | ||
| Q2 24 | -665.7% | -35.8% | ||
| Q1 24 | -2652.9% | -93.9% |
净利率FATELEDS
| Q4 25 | — | -28.9% | ||
| Q3 25 | -1852.4% | -9.0% | ||
| Q2 25 | -1786.6% | 1.3% | ||
| Q1 25 | -2309.5% | 3.6% | ||
| Q4 24 | — | -43.4% | ||
| Q3 24 | -1551.0% | — | ||
| Q2 24 | -567.4% | -24.1% | ||
| Q1 24 | -2493.7% | -63.1% |
每股收益（稀释后）FATELEDS
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.27 | $-0.15 | ||
| Q2 25 | $-0.29 | $0.03 | ||
| Q1 25 | $-0.32 | $0.05 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.40 | — | ||
| Q2 24 | $-0.33 | $-0.04 | ||
| Q1 24 | $-0.47 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.7M | $2.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $207.2M | $2.1M |
| 总资产 | $318.9M | $14.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FATELEDS
| Q4 25 | $203.7M | $2.9M | ||
| Q3 25 | $215.4M | $2.6M | ||
| Q2 25 | $222.8M | $2.4M | ||
| Q1 25 | $240.4M | $2.4M | ||
| Q4 24 | $279.1M | $1.2M | ||
| Q3 24 | $296.9M | $1.7M | ||
| Q2 24 | $304.9M | $1.7M | ||
| Q1 24 | $121.3M | $1.6M |
总债务FATELEDS
| Q4 25 | — | — | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $3.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FATELEDS
| Q4 25 | $207.2M | $2.1M | ||
| Q3 25 | $234.1M | $2.8M | ||
| Q2 25 | $261.4M | $4.0M | ||
| Q1 25 | $288.4M | $3.6M | ||
| Q4 24 | $318.7M | $1.6M | ||
| Q3 24 | $362.3M | $2.2M | ||
| Q2 24 | $397.0M | $2.7M | ||
| Q1 24 | $426.1M | $3.0M |
总资产FATELEDS
| Q4 25 | $318.9M | $14.2M | ||
| Q3 25 | $343.7M | $15.6M | ||
| Q2 25 | $371.6M | $23.2M | ||
| Q1 25 | $398.7M | $23.2M | ||
| Q4 24 | $440.7M | $10.4M | ||
| Q3 24 | $495.0M | $11.1M | ||
| Q2 24 | $528.8M | $11.5M | ||
| Q1 24 | $569.9M | $12.0M |
负债/权益比FATELEDS
| Q4 25 | — | — | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-106.1M | $361.0K |
| 自由现金流经营现金流 - 资本支出 | $-112.0M | $331.0K |
| 自由现金流率自由现金流/营收 | -8183.9% | 12.9% |
| 资本支出强度资本支出/营收 | 434.8% | 1.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-199.6M | — |
8季度趋势，按日历期对齐
经营现金流FATELEDS
| Q4 25 | $-106.1M | $361.0K | ||
| Q3 25 | $-24.4M | — | ||
| Q2 25 | $-24.6M | $693.0K | ||
| Q1 25 | $-33.8M | $1.4M | ||
| Q4 24 | $-122.9M | $-158.0K | ||
| Q3 24 | $-29.4M | — | ||
| Q2 24 | $-32.3M | $109.0K | ||
| Q1 24 | $-33.4M | $-600.0K |
自由现金流FATELEDS
| Q4 25 | $-112.0M | $331.0K | ||
| Q3 25 | $-26.6M | — | ||
| Q2 25 | $-25.9M | $383.0K | ||
| Q1 25 | $-35.0M | $1.3M | ||
| Q4 24 | $-123.6M | $-276.0K | ||
| Q3 24 | $-29.9M | — | ||
| Q2 24 | $-32.4M | $98.0K | ||
| Q1 24 | $-33.4M | $-619.0K |
自由现金流率FATELEDS
| Q4 25 | -8183.9% | 12.9% | ||
| Q3 25 | -1526.5% | — | ||
| Q2 25 | -1360.7% | 2.2% | ||
| Q1 25 | -2148.9% | 11.8% | ||
| Q4 24 | -6645.4% | -21.9% | ||
| Q3 24 | -973.1% | — | ||
| Q2 24 | -477.8% | 7.4% | ||
| Q1 24 | -1736.9% | -69.9% |
资本支出强度FATELEDS
| Q4 25 | 434.8% | 1.2% | ||
| Q3 25 | 126.5% | 0.2% | ||
| Q2 25 | 71.4% | 1.8% | ||
| Q1 25 | 73.4% | 1.1% | ||
| Q4 24 | 39.2% | 9.4% | ||
| Q3 24 | 16.1% | 9.3% | ||
| Q2 24 | 0.8% | 0.8% | ||
| Q1 24 | 4.5% | 2.1% |
现金转化率FATELEDS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.11× | ||
| Q1 25 | — | 3.62× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
